CRISPR: a journey of gene-editing based medicine

被引:7
作者
Golkar, Zhabiz [1 ]
机构
[1] Voorhees Coll, Div Acad Affairs, Denmark, SC 29042 USA
关键词
CRISPR; Gene-editing; Cas; Bacteria; Adaptive immunity; Medicine; DNA; Ethic; IMMUNE-SYSTEM; STEM-CELL; MUSCULAR-DYSTROPHY; ANTIVIRAL DEFENSE; DNA METHYLATION; GENOME; CANCER; RNA; REPEATS; DISEASE;
D O I
10.1007/s13258-020-01002-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is one of the hallmark of biological tools, contemplated as a valid and hopeful alternatives to genome editing. Advancements in CRISPR-based technologies have empowered scientists with an editing kit that allows them to employ their knowledge for deleting, replacing and lately "Gene Surgery", and provides unique control over genes in broad range of species, and presumably in humans. These fast-growing technologies have high strength and flexibility and are becoming an adaptable tool with implementations that are altering organism's genome and easily used for chromatin manipulation. In addition to the popularity of CRISPR in genome engineering and modern biology, this major tool authorizes breakthrough discoveries and methodological advancements in science. As scientists are developing new types of experiments, some of the applications are raising questions about what CRISPR can enable. The results of evidence-based research strongly suggest that CRISPR is becoming a practical tool for genome-engineering and to create genetically modified eukaryotes, which is needed to establish guidelines on new regulatory concerns for scientific communities.
引用
收藏
页码:1369 / 1380
页数:12
相关论文
共 131 条
  • [1] Abbott A, 2016, NATURE, V532, P432, DOI 10.1038/532432a
  • [2] The CRISPR tool kit for genome editing and beyond
    Adli, Mazhar
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [3] Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
    Allen, Alexander G.
    Chung, Cheng-Han
    Atkins, Andrew
    Dampier, Will
    Khalili, Kamel
    Nonnemacher, Michael R.
    Wigdahl, Brian
    [J]. FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [4] CRISPR-Cas Functional Module Exchange in Escherichia coli
    Almendros, Cristobal
    Mojica, Francisco J. M.
    Diez-Villasenor, Cesar
    Guzman, Noemi M.
    Garcia-Martinez, Jesus
    [J]. MBIO, 2014, 5 (01):
  • [5] Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
    Annunziato, Stefano
    Kas, Sjors M.
    Nethe, Micha
    Yucel, Hatice
    Del Bravo, Jessica
    Pritchard, Colin
    Bin Ali, Rahmen
    van Gerwen, Bas
    Siteur, Bjorn
    Drenth, Anne Paulien
    Schut, Eva
    van de Ven, Marieke
    Boelens, Mirjam C.
    Klarenbeek, Sjoerd
    Huijbers, Ivo J.
    van Miltenburg, Martine H.
    Jonkers, Jos
    [J]. GENES & DEVELOPMENT, 2016, 30 (12) : 1470 - 1480
  • [6] A prudent path forward for genomic engineering and germline gene modification
    Baltimore, David
    Berg, Paul
    Botchan, Michael
    Carroll, Dana
    Charo, R. Alta
    Church, George
    Corn, Jacob E.
    Daley, George Q.
    Doudna, Jennifer A.
    Fenner, Marsha
    Greely, Henry T.
    Jinek, Martin
    Martin, G. Steven
    Penhoet, Edward
    Puck, Jennifer
    Sternberg, Samuel H.
    Weissman, Jonathan S.
    Yamamoto, Keith R.
    [J]. SCIENCE, 2015, 348 (6230) : 36 - 38
  • [7] CRISPR provides acquired resistance against viruses in prokaryotes
    Barrangou, Rodolphe
    Fremaux, Christophe
    Deveau, Helene
    Richards, Melissa
    Boyaval, Patrick
    Moineau, Sylvain
    Romero, Dennis A.
    Horvath, Philippe
    [J]. SCIENCE, 2007, 315 (5819) : 1709 - 1712
  • [8] Barton A, 2017, SHOULD WE WORRY ERA
  • [9] Bengtsson NiclasE., 2017, NAT COMMUN, V8
  • [10] Modeling human disease in rodents by CRISPR/Cas9 genome editing
    Birling, Marie-Christine
    Herault, Yann
    Pavlovic, Guillaume
    [J]. MAMMALIAN GENOME, 2017, 28 (7-8) : 291 - 301